Small molecule drugs are the mainstay of medicine, also representing an emerging area of research and development focus in the immunotherapy industry. Small molecule drugs targeting defined pathways and cells capable of immune modulation are expected to substantially improve the efficacy of cancer immunotherapy. To support new drug research and development, Creative Biolabs offers an integrated small molecule drug discovery process that efficiently identifies small molecules suitable for drug development.

This brochure provides details of Creative Biolabs' chemistry services, including:

1. Medicinal chemistry service
2. Analytical chemistry service
3. Synthetic chemistry service